BioSpace News Archive

Cardinal Health launched the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate.

Anixa Biosciences, Inc. announced that the Company will present at the 2022 Virtual Growth Conference, hosted by M-Vest, a division of Maxim Group LLC, on March 28th – 30th from 9:00 am – 5:00 pm EDT.

Heron Therapeutics, Inc. today announced that Health Canada has issued a Notice of Compliance (NOC) to commercialize ZYNRELEF (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures.

NEXGEL, Inc. today announced that it will report its financial and operating results for the fourth quarter and full year of 2021 after the market closes on Monday, March 21, 2022.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced publication of results from the Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy for the treatment of adults with severe hemophilia A, in the New England Journal of Medicine (NEJM).

Nonalcoholic fatty liver disease is one of the leading causes of death worldwide. However, why premenopausal women are more resistant to NAFLD than men is currently unknown.

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries.

Amolyt Pharma today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for the ongoing AZP-3601 clinical proof-of-concept trial in patients with hypoparathyroidism.

Armas Pharmaceuticals, Inc. and Steriscience have today announced an exclusive partnership for the distribution and supply of products for the U.S. market.

Allerpops, a local allergy-relief business, today announced the approval of a clinical trial for its product promoting all-natural allergy relief.